Concepedia

Suganya Cheyyatraivendran Arularasu

SC

Statistics

Publications

5

Citations

214

H-Index

5

Active since

2012

Affiliations

National University Health System(Current)

National University of Singapore

Agency for Science, Technology and Research

Institute of Molecular and Cell Biology

Public Health Agency of Sweden

Suganya Cheyyatraivendran Arularasu is an author at National University Health System specializing in monoclonal antibodies, host cell receptor binding, and severe acute respiratory syndrome.

Publications per year

2012–2020

5

Publications

5

Monoclonal antibodies for the S2 subunit of spike of SARS-CoV-1 cross-react with the newly-emerged SARS-CoV-2

Zhiqiang Zheng, Vanessa Monteil, Sebastian Maurer‐Stroh et al. · Eurosurveillance · 2020 · 85 citations · Full text

, , +15

Angiogenic peptide nanofibers repair cardiac tissue defect after myocardial infarction

Abdul Jalil Rufaihah, Immihan Ceren Yasa, Vaibavi Srirangam Ramanujam et al. · Acta Biomaterialia · 2017 · 55 citations · Full text

, , +16

Human Wharton's Jelly stem cell conditioned medium and cell‐free lysate inhibit human osteosarcoma and mammary carcinoma cell growth in vitro and in xenograft mice

Kalamegam Gauthaman, Chui‐Yee Fong, Suganya Cheyyatraivendran Arularasu et al. · Journal of Cellular Biochemistry · 2012 · 37 citations

, , +13

Monoclonal antibodies for the S2 subunit of spike of SARS-CoV cross-react with the newly-emerged SARS-CoV-2

Zhiqiang Zheng, Vanessa Monteil, Sebastian Maurer‐Stroh et al. · bioRxiv (Cold Spring Harbor Laboratory) · 2020 · 25 citations · Full text

, , +16

Contribution of Fc-dependent cell-mediated activity of a vestigial esterase-targeting antibody against H5N6 virus infection

Zhiqiang Zheng, Su Hui Catherine Teo, Suganya Cheyyatraivendran Arularasu et al. · Emerging Microbes & Infections · 2020 · 12 citations · Full text

, , +17

1–5 of 5